Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Sumatriptan’s Anti-Inflammatory Evidence: A Review
2026-09-24
Ala and colleagues systematically reviewed evidence that sumatriptan may influence inflammatory signaling beyond its established use in migraine, including effects on cytokines, nitric oxide pathways, and CGRP release. Their synthesis highlights promising protection across experimental injury models, while the mainly preclinical evidence and variation among studies mean that these findings do not establish new clinical indications.
-
T0070907 for Testing PPARγ in Vascular SASP
2026-09-24
T0070907 is a potent PPARγ antagonist that can help researchers test whether PPARγ activity contributes to anti-inflammatory signaling in foam cells. This article translates recent RXRα/PPARγ/NEDD4 findings into a careful assay strategy, emphasizing causal interpretation, species limits, and orthogonal validation.
-
3-Hydroxybutyrate (BHBA) for Stroke Assays
2026-09-23
Use 3-hydroxybutyrate (BHBA) to test whether a defined ketone-body signal can support neuronal resilience during ischemia-like stress. This practical guide separates BHBA-specific effects from mixed-ketone findings and pairs dose selection with ferroptosis-focused readouts and troubleshooting.
-
Vitamin C: Redox Logic for Senescence Assays
2026-09-23
Vitamin C is a context-dependent redox regulator with distinct effects in tumor and cochlear cell models. This article translates ROS/NF-κB evidence into practical assay decisions, dose interpretation, and translational limits.
-
Fiber Density Reconstructs Annulus Fibrosus Collagen
2026-09-22
The reference study shows that fiber density in otherwise composition-matched electrospun scaffolds can direct annulus fibrosus cell phenotypes toward collagen type I- or collagen type II-rich matrix programs. Its mechanistic findings connect scaffold microarchitecture with RhoA–ROCK, ERK/AKT, and Piezo1-associated signaling, offering a design principle for rebuilding the native collagen heterogeneity of the annulus fibrosus.
-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-09-22
Grafton et al. developed a high-content screening workflow that combines induced pluripotent stem cell-derived cardiomyocytes with deep-learning image analysis to identify potential drug-induced cardiotoxicity. The approach produced a single-parameter toxicity score across bioactive and chemically diverse libraries, offering an early-stage strategy for prioritizing compounds that require mechanistic and safety follow-up.
-
Bafilomycin C1 in High-Content Cell Assays
2026-09-21
Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that links lysosomal pH control with rigorous high-content assay design. This guide translates deep-learning phenotyping in iPSC-derived cardiomyocytes into practical decisions for autophagy, toxicity, and mechanistic cell biology workflows.
-
Butyrate, Lysosomal Fe2+, and Lung Cancer Stemness
2026-09-21
The Heliyon study shows that butyrate attenuates lung cancer stemness through a ferroptosis mechanism involving lysosomal Fe2+ recruitment and reduced SLC7A11 protein stability. Its combined functional, molecular, and in vivo design connects subcellular iron handling with cancer stem cell behavior and chemotherapy sensitivity.
-
Diphenyleneiodonium Chloride in Redox Assays
2026-09-20
Diphenyleneiodonium chloride enables controlled interrogation of oxidant-generating enzymes while also revealing GPR3-linked cAMP responses. This workflow pairs DPI pharmacology with time-resolved Nrf2 measurements to separate early oxidative signaling from later proteasome-associated pathway loss.
-
Bafilomycin C1 for Autophagy Assays
2026-09-19
Bafilomycin C1 provides a practical way to connect lysosomal acidification with autophagy, toxicity, and high-content phenotypes. This workflow shows how to use a vacuolar H+-ATPases inhibitor alongside deep-learning image analysis and orthogonal controls without mistaking general cell death for a specific mechanism.
-
RIPostC, Ketone Bodies, and Ferroptosis in Stroke
2026-09-18
A 2024 ACS Chemical Neuroscience study identifies ketone body production and ferroptosis suppression as a mechanistic link between remote ischemic postconditioning and neuroprotection after ischemic stroke. Its rat and HT22-cell experiments connect improved energy metabolism with GPX4 preservation, ACSL4 reduction, iron control, and mitochondrial protection, providing a framework for testing 3-hydroxybutyrate and related metabolic interventions.
-
IL-2, Human Recombinant in Neuronal Granule Studies
2026-09-18
Explore how IL-2, human recombinant can serve as a defined signaling perturbation in studies of neuronal granules, FUS phase separation, and SMN function. This article separates established Cell Reports mechanisms from testable cytokine-based experimental applications.
-
LG 101506: RXR Signaling to Immune Translation
2026-09-17
A translational framework for using LG 101506 to interrogate RXR biology, connect nuclear receptor signaling with immune-checkpoint phenotypes, and test—not assume—relationships between RXR activity and the RBMS1–B4GALT1–PD-L1 axis in triple-negative breast cancer.
-
Metabolic Sensitization of Ferroptosis and Cuproptosis
2026-09-17
Zhang and colleagues developed a Cu–tannic acid/liposome nanosystem carrying STF-31 to inhibit glycolysis and compensatory NAD+ metabolism, thereby increasing tumor-cell susceptibility to ferroptosis and cuproptosis. The study connects metabolic depletion with copper retention, redox failure, immunogenic cell death, and tumor immune remodeling, offering a mechanistic framework for combination nanomedicine design.
-
Rocilinostat (ACY-1215) Experimental Workflow
2026-09-16
Rocilinostat (ACY-1215) enables selective HDAC6 target-engagement studies, multiple myeloma viability testing, and carefully controlled proteasome-inhibitor combination experiments. This workflow also shows how α-tubulin acetylation can support hypothesis-generating cilia studies without confusing cancer evidence with developmental biology evidence.